SETting Up for Epigenetic Regulation of Advanced Prostate Cancer.

Thienger, Phillip; Rubin, Mark A. (2020). SETting Up for Epigenetic Regulation of Advanced Prostate Cancer. Cancer cell, 38(3), pp. 309-311. Cell Press 10.1016/j.ccell.2020.08.009

[img] Text
1-s2.0-S1535610820304207-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (869kB) | Request a copy

An outgrowth of therapy-resistant prostate cancers (PCa) with enhanced metastatic potential may be triggered by inhibitors of androgen receptor (AR) signaling, often via epigenetic rewiring. In this issue of Cancer Cell, Yuan et al. demonstrate how SETD2 integrates EZH2 and AMPK signaling pathways to keep PCa metastasis in check.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Thienger, Phillip Dominik and Rubin, Mark Andrew

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1535-6108

Publisher:

Cell Press

Language:

English

Submitter:

Marla Rittiner

Date Deposited:

29 Dec 2020 09:57

Last Modified:

29 Dec 2020 09:57

Publisher DOI:

10.1016/j.ccell.2020.08.009

PubMed ID:

32931739

BORIS DOI:

10.48350/150211

URI:

https://boris.unibe.ch/id/eprint/150211

Actions (login required)

Edit item Edit item
Provide Feedback